Cell Therapy

Final product formulation for cell therapy!

Limbo is a technology capable of reducing the toxicity associated to the cryopreservation of cells, at the same time that providing an enclosed final product formulation at the point of care for cryopreserved cell therapy products. This solution addresses the need for cell recovery standardization protocols at the point of care as well as reducing contamination risks associated to cell therapy product handling.

View more details in the PDF below: